MetaCap

Curanex Pharmaceuticals (CURX) vs Alaunos Therapeutics (TCRT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Alaunos Therapeutics is the larger company by market cap ($7.0 million vs $6.9 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CURX-7.54%TCRT+98.07%
+288%+133%-22%
Oct 7, 20261 yearNov 20, 2026
CURX-16.94%TCRT+111.25%
+247%+109%-30%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CURX versus TCRT key metrics
MetricCURXTCRT
Share price$4.41$1.66
Market cap$6.92M$6.99M
1-day change-0.67%+3.75%
EPS (TTM)$-8.78$-1.76
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$5.00K
Revenue growth (YoY)—-50.00%
Net income (latest FY)$-4.23M$-4.18M
Operating margin—-84500.00%
Net margin—-83520.00%
52-week high$13.34$4.50
52-week low$3.58$0.72
Distance from 52-week high-66.94%-63.11%
Average volume17.83K7.56M
Shares outstanding1.57M4.21M
Employees61
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Curanex Pharmaceuticals

CURX stock →

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout.

Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees

About Alaunos Therapeutics

TCRT stock →

Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs.

Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees

CURX vs TCRT FAQ

Which is bigger, Curanex Pharmaceuticals or Alaunos Therapeutics?

Alaunos Therapeutics (TCRT) is larger, with a market capitalization of $6.99M compared with $6.92M for Curanex Pharmaceuticals (CURX).

Are Curanex Pharmaceuticals and Alaunos Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons